The University of Tartu is a university in the city of Tartu in Estonia. It is the national university of Estonia. It is the only classical university in the country, and also its biggest and most prestigious university.

During the past decade, University of Tartu conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Tartu" #1 sponsor was "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 1 trials, followed by "Javier P. Gisbert" with 1 trials sponsored, "Masaryk University" with 1 trials sponsored, "Maxim Pharmaceuticals" with 1 trials sponsored and "Retrotope, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tartu" #1 collaborator was "University of Tartu" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Tartu" are "Adverse Reaction to Vaccine" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Breast Cancer" (1 trials), "COVID19 Vaccine" (1 trials) and "H. Pylori Infection" (1 trials). Many other conditions were trialed in "University of Tartu" in a lesser frequency.

Most popular intervention types in "University of Tartu" are "Drug" (3 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZD1222" (1 trials), "BBV152" (1 trials), "BNT162b2" (1 trials), "CMF regimen" (1 trials) and "CVnCoV" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Tartu" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Tartu". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Tartu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Tartu, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".